
2008 | 2007 | 2006 | 2005
May 2008
Digitek® Recall
Effective immediately, Digitek® (digoxin tablets, USP, all strengths), made by Actavis Totowa LLC and distributed under the Bertek and UDL labels, is being voluntarily withdrawn from the market. This withdrawal is due to the possibility that tablets with double the appropriate thickness (and double the active ingredient) were released commercially. This recall is being conducted with the knowledge of the Food and Drug Administration. For more information on this withdrawal, visit the FDA’s website at http://www.fda.gov/oc/po/firmrecalls/actavis04_08.html or call Actavis at 1-888-276-6166.
April 2008
Neupro® Recall
Neupro® (rotigotine transdermal system) patches, made by Schwarz Pharma, a company of the UCB group, are being recalled in the United States and will not be available after the end of April 2008.
Some Neupro patches have snowflake-like patterns on them. The more snowflakes you see, the less likely it is that the patch will work properly. Click here to view an image of a patch with a snowflake-like pattern. Patches that look like this should not be used.
Information is also available on the FDA’s website http://www.fda.gov/medwAtch/safety/2008/safety08.htm#neupro.
February 2008
Heparin Recall
Baxter International Inc. announced today that the company is proceeding with a voluntary recall of all remaining lots and doses of its heparin sodium injection multi-dose, single-dose vials, and HEP-LOCK heparin flush products.
More information on this recall is available on the U.S. Food and Drug Administration’s website.
Duragesic-Fentanyl Recall
Effective immediately, as a precaution all lots of 25 mcg/hr DURAGESIC® (fentanyl transdermal system) CII PAIN PATCHES sold by PriCara™ in the United States and all 25 mcg/hr fentanyl patches sold by Sandoz Inc. in the United States have been voluntarily recalled from wholesalers and pharmacies. The recalled patches all have expiration dates on or before December 2009 and are manufactured by ALZA Corporation, an affiliate
of PriCara.
More information on this recall is available on the U.S. Food and Drug Administration’s website. The information includes a warning that you should not handle the cut patches directly.
|